写SCI论文,行话多好还是说人话好?Science表态了

2021-04-15 Oranhgy MedSci原创

在跨学科时代,使用过多术语可能会阻碍没有共同科学背景的科学家之间的有效交流。关于行话如何限制科学知识传播的问题早已争论不休,但很少定量地解决。

以往写SCI研究,经常听到的建议是尽量多用专业术语,避免平铺直叙和白话连篇。专业术语也叫行话,特别是医学领域,医学专业文献里,术语层峦叠嶂,很多词不明觉厉,在外行人看来,即便每一个字都认识,放在一起也不知道是什么意思。那么,学术论文真的需要这么多术语吗?

MICROSTOCKHUB/ISTOCK

近日,发表在英国皇家学会期刊Proceedings of the Royal Society B的文章就术语的使用与引文之间的关系进行分析。

洞穴研究是一个多学科领域,尤其容易产生术语专业化,并且同龄人之间在语言上存在分歧。洞穴研究一直是具有不同科学背景的几代科学家的碰撞点,涵盖地质学家、动物学家、人类学家、流行病学家、生态学家和进化生物学家。因此研究者选用洞穴研究进行分析。

研究人员计算了21486篇研究术语在每篇文章的标题和摘要中相对于单词总数的比例。析结果发现,其中被引用最多的论文,标题中没有使用任何洞穴科学的专门术语;摘要中,行话的比例不超过文本的1%。相反,大量使用行话的论文被引用的频率要低得多,摘要中的行话比例一旦超过1%,被引用量急剧下降。

常用术语使用对引文影响

摘要中的行话比例与标题之间的相关性。

鉴于这些发现,作者建议科学家们将术语归入论文的后期方法部分,因为同领域专家会更多了解该部分。

针对该研究,Science也给予肯定与回应,指出该研究发现不仅是在洞穴研究领域,在医学领域也具有相同的模式。

Science

昆士兰科技大学的统计学教授drian Barnett曾研究过科学论文中缩写词的使用,他承认这其中的权衡,"好的写作需要时间,相对而言不太好的写作仍然会被发表,因此,研究人员不会花更多时间改进其论文风格。但是该研究的发现暗示了更好的写作会被更多人认可和引用。

不过,并不是每个人都同意该研究的结论。乌克兰地质科学研究所的首席科学家Alexander Klimchouk指出,专业术语可以让研究者更准确、更丰富地表达含义和概念。

美国蒙大拿州立大学的物理学教授Shannon Willoughby则表示,行话是否合适 "真的取决于听众。和同领域人群会多用术语,和不同领域人群交谈则会减少行话。

在跨学科时代,使用过多术语可能会阻碍没有共同科学背景的科学家之间的有效交流。关于行话如何限制科学知识传播的问题早已争论不休,但很少定量地解决。

总之就是,科学对人类物质文明的推动作用是显而易见的。它促进了社会生产力的发展,提高了人类的生活质量,也使人类的劳动条件得以改善。科学的目的是为人类提供新的认识外部世界和自身的途径,带来巨大的利益和效益,为人类提供了传播思想文化的新手段,使精神文明建设有了新的载体,对于丰富人们的精神生活,更新人们的思想观念,破除迷信等具有重要意义同时对于丰富人类的物质生活,提高人类生活质量的改善提供了巨大的帮助。能让每个人都理解,才是科学真正价值所在,对于研究文章而言,简介明了说人话或许也是一大优点。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1061224, encodeId=62371061224ea, content=说人话最重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211018/e648478f45134bf98bb9c0077683255e/b0eb353793af4e328a1eaf3dd27f66a1.jpg, createdBy=3ed85634864, createdName=ms9000001019111034, createdTime=Sun Oct 17 14:30:05 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957283, encodeId=e1a695e28333, content=三人行,必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入,添加【梅斯医学科研助手WeChat:medsci_2021】邀您进群! 【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。 【入群福利】👉 群内可实时交流病例,提问同行,跨群讨论,每天更新前沿医学资讯和指南共识,每周推出至少1场专业直播,不时共享科研干货,入群即可获得100份SCI写作攻略!, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/a7082efd72134f339011deffae56d660/9f9bdab2a00341ce92bf6fd196c67f81.png, createdBy=4e205474392, createdName=七安, createdTime=Thu Apr 15 14:50:47 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376277, encodeId=fe7b13e6277c0, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Sat Apr 17 02:13:08 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404504, encodeId=7048140450402, content=<a href='/topic/show?id=10aa1603137' target=_blank style='color:#2F92EE;'>#SCI论文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16031, encryptionId=10aa1603137, topicName=SCI论文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c572475119, createdName=般若傻瓜, createdTime=Sat Apr 17 02:13:08 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957427, encodeId=378e95e4277e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32135480930, createdName=ms2000000528348546, createdTime=Thu Apr 15 22:04:53 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957252, encodeId=70ef95e25200, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201112/30c335774aa544ffb8c24cb0c0fe597a/005e6394a4cc41db889c661d567dca54.jpg, createdBy=c6f52266809, createdName=你合成, createdTime=Thu Apr 15 12:57:51 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957240, encodeId=2b2395e240f6, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b341321986, createdName=daiql1989, createdTime=Thu Apr 15 11:37:51 CST 2021, time=2021-04-15, status=1, ipAttribution=)]
    2021-10-17 ms9000001019111034

    说人话最重要

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1061224, encodeId=62371061224ea, content=说人话最重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211018/e648478f45134bf98bb9c0077683255e/b0eb353793af4e328a1eaf3dd27f66a1.jpg, createdBy=3ed85634864, createdName=ms9000001019111034, createdTime=Sun Oct 17 14:30:05 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957283, encodeId=e1a695e28333, content=三人行,必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入,添加【梅斯医学科研助手WeChat:medsci_2021】邀您进群! 【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。 【入群福利】👉 群内可实时交流病例,提问同行,跨群讨论,每天更新前沿医学资讯和指南共识,每周推出至少1场专业直播,不时共享科研干货,入群即可获得100份SCI写作攻略!, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/a7082efd72134f339011deffae56d660/9f9bdab2a00341ce92bf6fd196c67f81.png, createdBy=4e205474392, createdName=七安, createdTime=Thu Apr 15 14:50:47 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376277, encodeId=fe7b13e6277c0, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Sat Apr 17 02:13:08 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404504, encodeId=7048140450402, content=<a href='/topic/show?id=10aa1603137' target=_blank style='color:#2F92EE;'>#SCI论文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16031, encryptionId=10aa1603137, topicName=SCI论文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c572475119, createdName=般若傻瓜, createdTime=Sat Apr 17 02:13:08 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957427, encodeId=378e95e4277e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32135480930, createdName=ms2000000528348546, createdTime=Thu Apr 15 22:04:53 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957252, encodeId=70ef95e25200, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201112/30c335774aa544ffb8c24cb0c0fe597a/005e6394a4cc41db889c661d567dca54.jpg, createdBy=c6f52266809, createdName=你合成, createdTime=Thu Apr 15 12:57:51 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957240, encodeId=2b2395e240f6, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b341321986, createdName=daiql1989, createdTime=Thu Apr 15 11:37:51 CST 2021, time=2021-04-15, status=1, ipAttribution=)]
    2021-04-15 七安

    三人行,必有我师。 #梅斯医学科研互助群# 欢迎您的加入,添加【梅斯医学科研助手WeChat:medsci_2021】邀您进群! 【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。 【入群福利】👉 群内可实时交流病例,提问同行,跨群讨论,每天更新前沿医学资讯和指南共识,每周推出至少1场专业直播,不时共享科研干货,入群即可获得100份SCI写作攻略!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1061224, encodeId=62371061224ea, content=说人话最重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211018/e648478f45134bf98bb9c0077683255e/b0eb353793af4e328a1eaf3dd27f66a1.jpg, createdBy=3ed85634864, createdName=ms9000001019111034, createdTime=Sun Oct 17 14:30:05 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957283, encodeId=e1a695e28333, content=三人行,必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入,添加【梅斯医学科研助手WeChat:medsci_2021】邀您进群! 【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。 【入群福利】👉 群内可实时交流病例,提问同行,跨群讨论,每天更新前沿医学资讯和指南共识,每周推出至少1场专业直播,不时共享科研干货,入群即可获得100份SCI写作攻略!, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/a7082efd72134f339011deffae56d660/9f9bdab2a00341ce92bf6fd196c67f81.png, createdBy=4e205474392, createdName=七安, createdTime=Thu Apr 15 14:50:47 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376277, encodeId=fe7b13e6277c0, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Sat Apr 17 02:13:08 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404504, encodeId=7048140450402, content=<a href='/topic/show?id=10aa1603137' target=_blank style='color:#2F92EE;'>#SCI论文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16031, encryptionId=10aa1603137, topicName=SCI论文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c572475119, createdName=般若傻瓜, createdTime=Sat Apr 17 02:13:08 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957427, encodeId=378e95e4277e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32135480930, createdName=ms2000000528348546, createdTime=Thu Apr 15 22:04:53 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957252, encodeId=70ef95e25200, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201112/30c335774aa544ffb8c24cb0c0fe597a/005e6394a4cc41db889c661d567dca54.jpg, createdBy=c6f52266809, createdName=你合成, createdTime=Thu Apr 15 12:57:51 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957240, encodeId=2b2395e240f6, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b341321986, createdName=daiql1989, createdTime=Thu Apr 15 11:37:51 CST 2021, time=2021-04-15, status=1, ipAttribution=)]
    2021-04-17 jichang
  4. [GetPortalCommentsPageByObjectIdResponse(id=1061224, encodeId=62371061224ea, content=说人话最重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211018/e648478f45134bf98bb9c0077683255e/b0eb353793af4e328a1eaf3dd27f66a1.jpg, createdBy=3ed85634864, createdName=ms9000001019111034, createdTime=Sun Oct 17 14:30:05 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957283, encodeId=e1a695e28333, content=三人行,必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入,添加【梅斯医学科研助手WeChat:medsci_2021】邀您进群! 【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。 【入群福利】👉 群内可实时交流病例,提问同行,跨群讨论,每天更新前沿医学资讯和指南共识,每周推出至少1场专业直播,不时共享科研干货,入群即可获得100份SCI写作攻略!, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/a7082efd72134f339011deffae56d660/9f9bdab2a00341ce92bf6fd196c67f81.png, createdBy=4e205474392, createdName=七安, createdTime=Thu Apr 15 14:50:47 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376277, encodeId=fe7b13e6277c0, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Sat Apr 17 02:13:08 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404504, encodeId=7048140450402, content=<a href='/topic/show?id=10aa1603137' target=_blank style='color:#2F92EE;'>#SCI论文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16031, encryptionId=10aa1603137, topicName=SCI论文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c572475119, createdName=般若傻瓜, createdTime=Sat Apr 17 02:13:08 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957427, encodeId=378e95e4277e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32135480930, createdName=ms2000000528348546, createdTime=Thu Apr 15 22:04:53 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957252, encodeId=70ef95e25200, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201112/30c335774aa544ffb8c24cb0c0fe597a/005e6394a4cc41db889c661d567dca54.jpg, createdBy=c6f52266809, createdName=你合成, createdTime=Thu Apr 15 12:57:51 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957240, encodeId=2b2395e240f6, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b341321986, createdName=daiql1989, createdTime=Thu Apr 15 11:37:51 CST 2021, time=2021-04-15, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1061224, encodeId=62371061224ea, content=说人话最重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211018/e648478f45134bf98bb9c0077683255e/b0eb353793af4e328a1eaf3dd27f66a1.jpg, createdBy=3ed85634864, createdName=ms9000001019111034, createdTime=Sun Oct 17 14:30:05 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957283, encodeId=e1a695e28333, content=三人行,必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入,添加【梅斯医学科研助手WeChat:medsci_2021】邀您进群! 【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。 【入群福利】👉 群内可实时交流病例,提问同行,跨群讨论,每天更新前沿医学资讯和指南共识,每周推出至少1场专业直播,不时共享科研干货,入群即可获得100份SCI写作攻略!, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/a7082efd72134f339011deffae56d660/9f9bdab2a00341ce92bf6fd196c67f81.png, createdBy=4e205474392, createdName=七安, createdTime=Thu Apr 15 14:50:47 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376277, encodeId=fe7b13e6277c0, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Sat Apr 17 02:13:08 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404504, encodeId=7048140450402, content=<a href='/topic/show?id=10aa1603137' target=_blank style='color:#2F92EE;'>#SCI论文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16031, encryptionId=10aa1603137, topicName=SCI论文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c572475119, createdName=般若傻瓜, createdTime=Sat Apr 17 02:13:08 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957427, encodeId=378e95e4277e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32135480930, createdName=ms2000000528348546, createdTime=Thu Apr 15 22:04:53 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957252, encodeId=70ef95e25200, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201112/30c335774aa544ffb8c24cb0c0fe597a/005e6394a4cc41db889c661d567dca54.jpg, createdBy=c6f52266809, createdName=你合成, createdTime=Thu Apr 15 12:57:51 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957240, encodeId=2b2395e240f6, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b341321986, createdName=daiql1989, createdTime=Thu Apr 15 11:37:51 CST 2021, time=2021-04-15, status=1, ipAttribution=)]
    2021-04-15 ms2000000528348546

    学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1061224, encodeId=62371061224ea, content=说人话最重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211018/e648478f45134bf98bb9c0077683255e/b0eb353793af4e328a1eaf3dd27f66a1.jpg, createdBy=3ed85634864, createdName=ms9000001019111034, createdTime=Sun Oct 17 14:30:05 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957283, encodeId=e1a695e28333, content=三人行,必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入,添加【梅斯医学科研助手WeChat:medsci_2021】邀您进群! 【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。 【入群福利】👉 群内可实时交流病例,提问同行,跨群讨论,每天更新前沿医学资讯和指南共识,每周推出至少1场专业直播,不时共享科研干货,入群即可获得100份SCI写作攻略!, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/a7082efd72134f339011deffae56d660/9f9bdab2a00341ce92bf6fd196c67f81.png, createdBy=4e205474392, createdName=七安, createdTime=Thu Apr 15 14:50:47 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376277, encodeId=fe7b13e6277c0, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Sat Apr 17 02:13:08 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404504, encodeId=7048140450402, content=<a href='/topic/show?id=10aa1603137' target=_blank style='color:#2F92EE;'>#SCI论文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16031, encryptionId=10aa1603137, topicName=SCI论文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c572475119, createdName=般若傻瓜, createdTime=Sat Apr 17 02:13:08 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957427, encodeId=378e95e4277e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32135480930, createdName=ms2000000528348546, createdTime=Thu Apr 15 22:04:53 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957252, encodeId=70ef95e25200, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201112/30c335774aa544ffb8c24cb0c0fe597a/005e6394a4cc41db889c661d567dca54.jpg, createdBy=c6f52266809, createdName=你合成, createdTime=Thu Apr 15 12:57:51 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957240, encodeId=2b2395e240f6, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b341321986, createdName=daiql1989, createdTime=Thu Apr 15 11:37:51 CST 2021, time=2021-04-15, status=1, ipAttribution=)]
    2021-04-15 你合成

    学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1061224, encodeId=62371061224ea, content=说人话最重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211018/e648478f45134bf98bb9c0077683255e/b0eb353793af4e328a1eaf3dd27f66a1.jpg, createdBy=3ed85634864, createdName=ms9000001019111034, createdTime=Sun Oct 17 14:30:05 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957283, encodeId=e1a695e28333, content=三人行,必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入,添加【梅斯医学科研助手WeChat:medsci_2021】邀您进群! 【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。 【入群福利】👉 群内可实时交流病例,提问同行,跨群讨论,每天更新前沿医学资讯和指南共识,每周推出至少1场专业直播,不时共享科研干货,入群即可获得100份SCI写作攻略!, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/a7082efd72134f339011deffae56d660/9f9bdab2a00341ce92bf6fd196c67f81.png, createdBy=4e205474392, createdName=七安, createdTime=Thu Apr 15 14:50:47 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376277, encodeId=fe7b13e6277c0, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Sat Apr 17 02:13:08 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404504, encodeId=7048140450402, content=<a href='/topic/show?id=10aa1603137' target=_blank style='color:#2F92EE;'>#SCI论文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16031, encryptionId=10aa1603137, topicName=SCI论文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c572475119, createdName=般若傻瓜, createdTime=Sat Apr 17 02:13:08 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957427, encodeId=378e95e4277e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32135480930, createdName=ms2000000528348546, createdTime=Thu Apr 15 22:04:53 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957252, encodeId=70ef95e25200, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201112/30c335774aa544ffb8c24cb0c0fe597a/005e6394a4cc41db889c661d567dca54.jpg, createdBy=c6f52266809, createdName=你合成, createdTime=Thu Apr 15 12:57:51 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957240, encodeId=2b2395e240f6, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b341321986, createdName=daiql1989, createdTime=Thu Apr 15 11:37:51 CST 2021, time=2021-04-15, status=1, ipAttribution=)]
    2021-04-15 daiql1989

    不错

    0

相关资讯

医学SCI论文的结构化写作(转载)

一篇优秀的SCI论文一般由规范而严谨的内容和适当的论文结构和语言表达构成。内容是文章的灵魂,语言结构是论文的骨架。本文系统的讲述医学SCI论文的结构化写作,希望对各位有所启发。

SCI论文的那些事@投稿的流程(上)

1、SCI论文是什么? SCI论文是说你的论文被检索机构SCI收录,SCI的全称是Science Citation Index科学引文索引。我们投稿时候需要关心的不是我们的论文会不会被检索,而是看投稿的杂志是不是被科学引文索引数据库所收录。 SCI论文,即为被SCI索引收录的期刊所刊登的论文,目前我国科技界对SCI论文概念模式,小部分研究者误认为SCI是一本期刊,而由于南京大学率先引用

论文发表趣事:1997年投稿,2021年发表,历经24年!

一篇文章1997年投稿,2021年才接收发表!这似乎创了一个记录!

科研写作必备,5个SCI论文写作辅助工具推荐

作为科研人员,英文阅读和写作是伴随着整个科研过程,尤其是在英文论文的写作过程中,我们需要借助一些辅助工具来改善中国式英语表达,提高英文论文的写作效率,不断提升自己的写作水平。今天利刃君就为大家带来5款英文论文写作过程中可能用得到的辅助工具,帮助大家更快更好的完成SCI论文写作,也祝每个科研工作者工作顺利,很快的拿到自己的学术成果。 1.谷歌翻译 官方网址:https://translate.g

林墨:新中国第一篇SCI论文

本文由于数据问题,暂时撤稿,更多资讯请关注Medsci.cn!

新规则已出!医生发SCI论文难度提升!

近几天来,大家都在疯传ICMJE的新规则:Data Sharing Statements for Clinical Trials — A Requirement of the International Committee of Medical Journal Editors。 我们主要从三个方面来讨论。最后讨论ICMJE的最新规则。 1、动物伦理和临床试验的伦理:课题设计完成,在

拓展阅读

皮肤科2022年发表的SCI论文大数据分析

由于我们对皮肤科疾病了解的局限性,本推文很可能存在谬误;也请各位同仁多多指正,以促进我们提供越来越高质量的推文。

妇产科2022年发表的SCI论文大数据分析

由于我们对风湿科疾病了解的局限性,本推文很可能存在谬误;也请各位同仁多多指正,以促进我们提供越来越高质量的推文。

泌尿外科2022年发表的SCI论文大数据分析

由于我们对泌尿科疾病了解的局限性,本推文很可能存在谬误;也请各位同仁多多指正,以促进我们提供越来越高质量的推文。

血液科2022年发表的SCI论文大数据分析

由于我们对血液科疾病了解的局限性,本推文很可能存在谬误;也请各位同仁多多指正,以促进我们提供越来越高质量的推文。

神经外科2022年发表的SCI论文大数据分析

由于我们对神经外科疾病了解的局限性,本推文很可能存在谬误;也请各位同仁多多指正,以促进我们提供越来越高质量的推文。

神经科2022年发表的SCI论文大数据分析

由于我们对神经科疾病了解的局限性,本推文很可能存在谬误;也请各位同仁多多指正,以促进我们提供越来越高质量的推文。